U.S. flag

An official website of the United States government

nsv482237

  • Variant Calls:2
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:6,667,011
  • Description:dup 6q27-qter, del 11q25-qter; The breakpoints of this variant are not well localised. This CNV may have large blocks of segmental duplication at the flanks which are polymorphic and make it near-impossible to say exactly where the breaks are.
  • Publication(s):Sharp et al. 2006

Links to Other Resources

Genome View

Select assembly:
Overlapping variant regions from other studies: 27474 SVs from 133 studies. See in: genome view    
Remapped(Score: Good):164,078,969-170,745,979Question Mark
Overlapping variant regions from other studies: 13591 SVs from 121 studies. See in: genome view    
Remapped(Score: Good):130,930,106-135,076,622Question Mark
Overlapping variant regions from other studies: 26716 SVs from 133 studies. See in: genome view    
Submitted cytogenetic164,500,001-171,115,067Question Mark
Overlapping variant regions from other studies: 13593 SVs from 121 studies. See in: genome view    
Submitted cytogenetic130,800,001-135,006,516Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeScoreAssemblyAssembly UnitReciprocitySequence IDChrOuter StartInner StopOuter Stop
nsv482237RemappedGoodGRCh38.p12Primary AssemblyFirst PassNC_000006.12Chr6164,078,969170,745,979-
nsv482237RemappedGoodGRCh38.p12Primary AssemblyFirst PassNC_000011.10Chr11130,930,106135,076,622-
nsv482237Submitted cytogeneticGRCh37 (hg19)Primary AssemblyNC_000006.11Chr6164,500,001-171,115,067
nsv482237Submitted cytogeneticGRCh37 (hg19)Primary AssemblyNC_000011.9Chr11130,800,001-135,006,516

Variant Call Information

Variant Call IDTypeSample IDMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationOther Calls in this Sample and Study
nssv3021972copy number gainIMR213BAC aCGHProbe signal intensityIntellectual DisabilityUncertain significanceSubmitternssv3021975
nssv3021975copy number lossIMR213BAC aCGHProbe signal intensityIntellectual DisabilityUncertain significanceSubmitternssv3021972

Variant Call Placement Information

Variant Call IDPlacement TypeScoreHGVSAssemblyReciprocitySequence IDChrOuter StartInner StopOuter Stop
nssv3021972RemappedGoodNC_000006.12:g.(16
4078969_?)_(170745
979_?)dup
GRCh38.p12First PassNC_000006.12Chr6164,078,969170,745,979-
nssv3021975RemappedGoodNC_000011.10:g.(13
0930106_?)_(135076
622_?)del
GRCh38.p12First PassNC_000011.10Chr11130,930,106135,076,622-
nssv3021972Submitted cytogeneticNC_000006.11:g.(16
4500001_?)_(?_1711
15067)dup
GRCh37 (hg19)NC_000006.11Chr6164,500,001-171,115,067
nssv3021975Submitted cytogeneticNC_000011.9:g.(130
800001_?)_(?_13500
6516)del
GRCh37 (hg19)NC_000011.9Chr11130,800,001-135,006,516

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDSample IDHGVSTypeSubject PhenotypeClinical InterpretationSource of InterpretationOther Calls in this Sample and Study
nssv3021972IMR213GRCh37: NC_000006.11:g.(164500001_?)_(?_171115067)dupcopy number gainIntellectual DisabilityUncertain significanceSubmitternssv3021975
nssv3021975IMR213GRCh37: NC_000011.9:g.(130800001_?)_(?_135006516)delcopy number lossIntellectual DisabilityUncertain significanceSubmitternssv3021972

No genotype data were submitted for this variant

Support Center